Patents by Inventor Jennifer Riggs-Sauthier

Jennifer Riggs-Sauthier has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • OLIGOMER-CONTAINING SUBSTITUTED AROMATIC TRIAZINE COMPOUNDS
    Publication number: 20160194294
    Abstract: The invention relates to (among other things) methods for treatment comprising administering oligomer-containing substituted aromatic triazine compounds. A compound of the invention, when administered by any of a number of administration routes, exhibits one or more advantages over corresponding compounds lacking the oligomer.
    Type: Application
    Filed: January 15, 2016
    Publication date: July 7, 2016
    Inventors: Jennifer Riggs-Sauthier, Bo-Liang Deng
  • Oligomer-containing benzamide-based compounds
    Patent number: 9375486
    Abstract: The invention relates to (among other things) oligomer-containing benzamide-based compounds. A compound of the invention exhibits one or more advantages over corresponding compounds lacking the oligomer.
    Type: Grant
    Filed: September 17, 2013
    Date of Patent: June 28, 2016
    Assignee: Nektar Therapeutics
    Inventors: Lin Cheng, Jennifer Riggs-Sauthier, Neel K. Anand
  • Oligomer-nucleoside phosphate conjugates
    Patent number: 9365604
    Abstract: The invention provides small molecule drugs that are chemically modified by covalent attachment of a water soluble, non-peptidic oligomer. The conjugates of the invention, when administered by any of a number administration routes, exhibits advantages over previously administered compounds.
    Type: Grant
    Filed: April 23, 2014
    Date of Patent: June 14, 2016
    Assignee: Nektar Therapeutics
    Inventors: Zhongxu Ren, Jennifer Riggs-Sauthier, Timothy A. Riley, Laurie A. VanderVeen, Aaron S. Hammons
  • MULTI-ARM POLYMERIC ALKANOATE CONJUGATES
    Publication number: 20160144045
    Abstract: Among other aspects, provided herein are multi-armed polymer conjugates comprising an alkanoate-linker, compositions comprising such conjugates, and related methods of making and administering the same. Methods of treatment employing such conjugates and related uses are also provided. The conjugates are prepared with high drug loading efficiencies.
    Type: Application
    Filed: November 23, 2015
    Publication date: May 26, 2016
    Inventors: Antoni Kozlowski, Samuel P. McManus, Jennifer Riggs-Sauthier, Xiaoming Shen, Wen Zhang
  • N-OPTIONALLY SUBSTITUTED ARYL-2-OLIGOMER-3-ALKOXYPROPIONAMIDES
    Publication number: 20160144047
    Abstract: The invention relates to (among other things) N-optionally substituted aryl-2-oligomer-3-alkoxypropionamides and compositions comprising the same. A compound of the invention, when administered by any of a number of administration routes, exhibits one or more advantages over corresponding compounds lacking the oligomer.
    Type: Application
    Filed: November 24, 2015
    Publication date: May 26, 2016
    Inventors: Jennifer Riggs-Sauthier, Wen Zhang
  • OLIGOMER MODIFIED DIAROMATIC SUBSTITUTED COMPOUNDS
    Publication number: 20160143904
    Abstract: The invention relates to (among other things) oligomer modified diaromatic substituted compounds. A compound of the invention, when administered by any of a number of administration routes, exhibits advantages over non-oligomer modified diaromatic substituted compounds.
    Type: Application
    Filed: November 24, 2015
    Publication date: May 26, 2016
    Inventors: Jennifer Riggs-Sauthier, Bo-Liang Deng
  • OLIGOMER-OPIOID AGONIST CONJUGATES
    Publication number: 20160130276
    Abstract: The invention provides compounds that are chemically modified by covalent attachment of a water-soluble oligomer. A compound of the invention, when administered by any of a number of administration routes, exhibits characteristics that are different from those of the compound not attached to the water-soluble oligomer.
    Type: Application
    Filed: December 4, 2015
    Publication date: May 12, 2016
    Inventors: Jennifer Riggs-Sauthier, Bo-Liang Deng, Timothy A. Riley
  • Oligomer-diarylpiperazine conjugates
    Patent number: 9314463
    Abstract: The invention relates to (among other things) oligomer-diarylpiperazine conjugates and related compounds. A conjugate of the invention, when administered by any of a number of administration routes, exhibits advantages over previously administered un-conjugated diarylpiperazine compounds.
    Type: Grant
    Filed: June 3, 2015
    Date of Patent: April 19, 2016
    Assignee: NEKTAR THERAPEUTICS
    Inventors: Zhongxu Ren, Jennifer Riggs-Sauthier
  • OLIGOMER-AMINO ACID CONJUGATES
    Publication number: 20160096799
    Abstract: The invention relates to (among other things) oligomer-amino acid conjugates and related compounds. A conjugate of the invention, when administered by any of a number of administration routes, exhibits advantages over un-conjugated amino acid compounds.
    Type: Application
    Filed: October 22, 2015
    Publication date: April 7, 2016
    Inventors: Xuyuan Gu, Jennifer Riggs-Sauthier
  • Oligomer-containing substituted aromatic triazine compounds
    Patent number: 9266845
    Abstract: The invention relates to (among other things) methods for treatment comprising administering oligomer-containing substituted aromatic triazine compounds. A compound of the invention, when administered by any of a number of administration routes, exhibits one or more advantages over corresponding compounds lacking the oligomer.
    Type: Grant
    Filed: October 30, 2014
    Date of Patent: February 23, 2016
    Assignee: Nektar Therapeutics
    Inventors: Jennifer Riggs-Sauthier, Bo-Liang Deng
  • Oligomer-opioid agonist conjugates
    Patent number: 9233167
    Abstract: The invention provides compounds that are chemically modified by covalent attachment of a water-soluble oligomer. A compound of the invention, when administered by any of a number of administration routes, exhibits characteristics that are different from those of the compound not attached to the water-soluble oligomer.
    Type: Grant
    Filed: December 23, 2014
    Date of Patent: January 12, 2016
    Assignee: Nektar Therapeutics
    Inventors: Jennifer Riggs-Sauthier, Bo-Liang Deng, Timothy A. Riley
  • Oligomer-aryloxy-substituted propanamine conjugates
    Patent number: 9233165
    Abstract: The invention relates to (among other things) oligomer-aryloxy-substituted propanamine conjugates and related compounds. A conjugate of the invention, when administered by any of a number of administration routes, exhibits advantages over un-conjugated aryloxy-substituted propanamine compounds.
    Type: Grant
    Filed: April 13, 2009
    Date of Patent: January 12, 2016
    Assignee: NEKTAR THERAPEUTICS
    Inventors: Jennifer Riggs-Sauthier, Franco J. Duarte
  • Oligomer-opioid agonist conjugates
    Patent number: 9233168
    Abstract: The invention provides compounds that are chemically modified by covalent attachment of a water-soluble oligomer. A compound of the invention, when administered by any of a number of administration routes, exhibits characteristics that are different from those of the compound not attached to the water-soluble oligomer.
    Type: Grant
    Filed: December 23, 2014
    Date of Patent: January 12, 2016
    Assignee: Nektar Therapeutics
    Inventors: Jennifer Riggs-Sauthier, Bo-Liang Deng, Timothy A. Riley
  • Oligomer-nitroimidazole anti-infective conjugates
    Patent number: 9233932
    Abstract: The invention provides (among other things) small molecule drugs that are chemically modified by covalent attachment of a water-soluble oligomer.
    Type: Grant
    Filed: September 4, 2014
    Date of Patent: January 12, 2016
    Assignee: Nektar Therapeutics
    Inventors: Zhongxu Ren, Jennifer Riggs-Sauthier, Michael D. Bentley
  • Oligomer-bis-chromonyl compound conjugates
    Patent number: 9233169
    Abstract: The invention provides oligomer-bis-chromonyl compound conjugates. The conjugates of the invention, when administered by any of a number of administration routes, exhibits advantages over previously administered compounds.
    Type: Grant
    Filed: February 20, 2015
    Date of Patent: January 12, 2016
    Assignee: Nektar Therapeutics
    Inventors: Jennifer Riggs-Sauthier, Bo-Liang Deng
  • Oligomer modified diaromatic substituted compounds
    Patent number: 9226970
    Abstract: Disclosed are compounds comprising diaromatic substituted compound residues, namely the anti-viral (anti-HIV) drug delavirdine, covalently attached via a linkage to water-soluble, non-peptidic oligomers, specifically to poly(ethylene glycol) (PEG) oligomers. A compound of the invention, when administered by any of a number of administration routes, exhibits advantages over non-oligomer modified diaromatic substituted compounds.
    Type: Grant
    Filed: February 22, 2011
    Date of Patent: January 5, 2016
    Assignee: Nektar Therapeutics
    Inventors: Jennifer Riggs-Sauthier, Bo-Liang Deng
  • N-optionally substituted aryl-2-oligomer-3-alkoxypropionamides
    Patent number: 9226971
    Abstract: The invention relates to (among other things) N-optionally substituted aryl-2-oligomer-3-alkoxypropionamides and compositions comprising the same. A compound of the invention, when administered by any of a number of administration routes, exhibits one or more advantages over corresponding compounds lacking the oligomer.
    Type: Grant
    Filed: October 14, 2011
    Date of Patent: January 5, 2016
    Assignee: Nektar Therapeutics
    Inventors: Jennifer Riggs-Sauthier, Wen Zhang
  • Multi-arm polymeric alkanoate conjugates
    Patent number: 9220790
    Abstract: Among other aspects, provided herein are multi-armed polymer conjugates comprising an alkanoate-linker, compositions comprising such conjugates, and related methods of making and administering the same. Methods of treatment employing such conjugates and related uses are also provided. The conjugates are prepared with high drug loading efficiencies.
    Type: Grant
    Filed: January 7, 2015
    Date of Patent: December 29, 2015
    Assignee: Naktar Therapeutics
    Inventors: Antoni Kozlowski, Samuel P. McManus, Jennifer Riggs-Sauthier, Xiaoming Shen, Wen Zhang
  • OLIGOMER-CONTAINING PYRROLIDINE COMPOUNDS
    Publication number: 20150366842
    Abstract: The invention relates to (among other things) oligomer-containing pyrrolidine compounds. A compound of the invention, when administered by any of a number of administration routes, exhibits one or more advantages over corresponding compounds lacking the oligomer.
    Type: Application
    Filed: June 26, 2015
    Publication date: December 24, 2015
    Inventor: Jennifer Riggs-Sauthier
  • OLIGOMER-CALCIUM CHANNEL BLOCKER CONJUGATES
    Publication number: 20150335628
    Abstract: The invention provides small molecule drugs that are chemically modified by covalent attachment of a water soluble oligomer. A conjugate of the invention, when administered by any of a number of administration routes, exhibits characteristics that are different from the characteristics of the small molecule drug not attached to the water soluble oligomer.
    Type: Application
    Filed: August 6, 2015
    Publication date: November 26, 2015
    Inventors: Zhongxu Ren, Bo-Liang Deng, Jennifer Riggs-Sauthier, Micah Harvey